Cargando…

VCAN Hypomethylation and Expression as Predictive Biomarkers of Drug Sensitivity in Upper Urinary Tract Urothelial Carcinoma

Versican (VCAN), also known as extracellular matrix proteoglycan 2, has been suggested as a potential biomarker in cancers. Previous research has found that VCAN is highly expressed in bladder cancer. However, its role in predicting outcomes for patients with upper urinary tract urothelial cancer (U...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Hao-Lun, Chang, Yin-Lun, Liu, Hui-Ying, Wu, Yen-Ting, Sung, Ming-Tse, Su, Yu-Li, Huang, Chun-Chieh, Wang, Pei-Chia, Peng, Jei-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139123/ https://www.ncbi.nlm.nih.gov/pubmed/37108649 http://dx.doi.org/10.3390/ijms24087486

Ejemplares similares

Hypomethylated RRBP1 Potentiates Tumor Malignancy and Chemoresistance in Upper Tract Urothelial Carcinoma
por: Luo, Hao-Lun, et al.
Publicado: (2021)

DNA Hypomethylation Is Associated with the Overexpression of INHBA in Upper Tract Urothelial Carcinoma
por: Kao, Chien-Chang, et al.
Publicado: (2022)

Aristolochic Acid Affects Upper Tract Urothelial Cancer Behavior through the MAPK Pathway
por: Chen, I-Hsuan, et al.
Publicado: (2019)

Methylation of SPARCL1 Is Associated with Oncologic Outcome of Advanced Upper Urinary Tract Urothelial Carcinoma
por: Luo, Hao-Lun, et al.
Publicado: (2019)

The prognostic impact of lymphovascular invasion for upper urinary tract urothelial carcinoma: A propensity score-weighted analysis
por: Chang, Yin Lun, et al.
Publicado: (2023)

Expression of Estrogen Receptor Beta Predicts Oncologic Outcome of pT3 Upper Urinary Tract Urothelial Carcinoma Better Than Aggressive Pathological Features
por: Luo, Hao Lun, et al.
Publicado: (2016)

The Prognostic Impact of Tumor Architecture for Upper Urinary Tract Urothelial Carcinoma: A Propensity Score-Weighted Analysis
por: Liu, Hui-Ying, et al.
Publicado: (2021)

Ureteroscopic biopsy of upper tract urothelial carcinoma and role of urinary biomarkers
por: Smentkowski, Katherine E., et al.
Publicado: (2020)

Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival
por: Su, Yu-Li, et al.
Publicado: (2020)

Propensity-Matched Survival Analysis of Upper Urinary Tract Urothelial Carcinomas between End-Stage Renal Disease with and without Kidney Transplantation
por: Luo, Hao Lun, et al.
Publicado: (2019)

Endoscopic Management of Upper Urinary Tract Urothelial Carcinoma
por: Park, Bong Hee, et al.
Publicado: (2013)

Conservative Treatment for Upper Urinary Tract Urothelial Carcinoma
por: Traxer, Olivier, et al.
Publicado: (2021)

Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
por: Chang, I-Wei, et al.
Publicado: (2016)

The Prognostic Impact of Tumor Location in pT3N0M0 Upper Urinary Tract Urothelial Carcinoma: A Retrospective Cohort Study
por: Chen, Tzu Shuang, et al.
Publicado: (2022)

Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract
por: Lee, Ji Yun, et al.
Publicado: (2017)

Time to change the management of upper urinary tract urothelial carcinoma
por: Akand, Murat, et al.
Publicado: (2020)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Referee
por: Grobet-Jeandin, Elisabeth, et al.
Publicado: (2021)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Con
por: Seles, Maximilian, et al.
Publicado: (2021)

Hypercalcemia an exceptional complication in upper urinary tract urothelial carcinoma
por: Jandou, Issam, et al.
Publicado: (2021)

Therapeutic strategies for asymptomatic upper urinary tract urothelial carcinoma
por: Lin, Deng, et al.
Publicado: (2022)

Clinical Determinants of Extraurinary Tract Recurrence and Survival after Radical Surgery for pT2 Upper Tract Urothelial Carcinoma
por: Huang, Yun-Ching, et al.
Publicado: (2023)

Gender Is a Significant Prognostic Factor for Upper Tract Urothelial Carcinoma: A Large Hospital-Based Cancer Registry Study in an Endemic Area
por: Huang, Chun-Chieh, et al.
Publicado: (2019)

Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure
por: Karanović, Sandra, et al.
Publicado: (2021)

Non-Invasive Biomarkers in the Diagnosis of Upper Urinary Tract Urothelial Carcinoma—A Systematic Review
por: Białek, Łukasz, et al.
Publicado: (2022)

Upper tract urinary cytology to detect upper tract urothelial carcinoma: Using the Johns Hopkins Hospital template and evaluation of its feasibility
por: Chen, Longwen, et al.
Publicado: (2015)

Recurrence pattern and TP53 mutation in upper urinary tract urothelial carcinoma
por: Chen, Chung-Hsin, et al.
Publicado: (2016)

The role of surgery on primary site in metastatic upper urinary tract urothelial carcinoma and a nomogram for predicting the survival of patients with metastatic upper urinary tract urothelial carcinoma
por: Zhang, Xiaodi, et al.
Publicado: (2021)

Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract
por: Lee, Hsiang-Ying, et al.
Publicado: (2017)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

Prognostic factors in laser treatment of upper urinary tract urothelial tumours
por: Niţă, Gh, et al.
Publicado: (2012)

Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract
por: Lonergan, Peter E., et al.
Publicado: (2020)

Preoperative sterile pyuria as a prognostic biomarker for intravesical recurrence in upper urinary tract urothelial carcinoma
por: Jeon, Byeong Jo, et al.
Publicado: (2020)

Prediction of survival in patients with upper tract urothelial carcinoma
por: Guo, Boda, et al.
Publicado: (2021)

The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence
por: Lee, Hsiang-Ying, et al.
Publicado: (2018)

Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder
por: Lee, Yi-Ying, et al.
Publicado: (2016)

TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR
por: Wang, Kun, et al.
Publicado: (2014)

Complement Component 1, s Subcomponent Overexpression is an Independent Poor Prognostic Indicator in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
por: Chang, I-Wei, et al.
Publicado: (2016)

Evaluation of Intraoperative Versus Postoperative Adjuvant Mitomycin C with Nephroureterectomy for Urothelial Carcinoma of the Upper Urinary Tract
por: Noennig, Blake, et al.
Publicado: (2018)

Radiofrequency-Treated Recurrence of Urothelial Carcinoma of the Upper Urinary Tract After Nephroureterectomy
por: Molina, Roberto, et al.
Publicado: (2014)

Upper Urinary Tract Urothelial Cancer in Croatian and Bosnian Endemic Nephropathy Regions
por: Samardzic, Josip, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_93235nphsm02ivd3verq4dqh24